Pandey R, Bakay M, Hakonarson H
Front Immunol. 2023; 14:1271102.
PMID: 38022642
PMC: 10643230.
DOI: 10.3389/fimmu.2023.1271102.
Tar I, Szegedi M, Krasuska-Slawinska E, Heropolitanska-Pliszka E, Bernatowska E, Oncu E
Cent Eur J Immunol. 2023; 48(3):228-236.
PMID: 37901871
PMC: 10604639.
DOI: 10.5114/ceji.2023.130874.
Mahdaviani S, Ghadimi S, Fallahi M, Hashemi-Moghaddam S, Chavoshzadeh Z, Puel A
BMC Surg. 2023; 23(1):289.
PMID: 37741967
PMC: 10517538.
DOI: 10.1186/s12893-023-02193-2.
Schwierzeck V, Effner R, Abel F, Reiger M, Notheis G, Held J
J Clin Immunol. 2022; 42(6):1301-1309.
PMID: 35655107
PMC: 9537231.
DOI: 10.1007/s10875-022-01293-7.
Puel A, Bastard P, Bustamante J, Casanova J
J Exp Med. 2022; 219(4).
PMID: 35319722
PMC: 8952682.
DOI: 10.1084/jem.20211387.
Hyper IgE Syndrome in an Isolated Population in Israel.
Lachover-Roth I, Lagovsky I, Shtorch-Asor A, Confino-Cohen R, Reinstein E, Garty B
Front Immunol. 2022; 13:829239.
PMID: 35185921
PMC: 8854367.
DOI: 10.3389/fimmu.2022.829239.
Profound differences in IgE and IgG recognition of micro-arrayed allergens in hyper-IgE syndromes.
Garib V, Ben-Ali M, Kundi M, Curin M, Yaakoubi R, Ben-Mustapha I
Allergy. 2021; 77(6):1761-1771.
PMID: 34653276
PMC: 9298271.
DOI: 10.1111/all.15143.
Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance.
Asano T, Khourieh J, Zhang P, Rapaport F, Spaan A, Li J
J Exp Med. 2021; 218(8).
PMID: 34137790
PMC: 8217968.
DOI: 10.1084/jem.20202592.
Pulmonary granulomatosis of genetic origin.
Bode S, Rohr J, Muller Quernheim J, Seidl M, Speckmann C, Heinzmann A
Eur Respir Rev. 2021; 30(160).
PMID: 33927005
PMC: 9488645.
DOI: 10.1183/16000617.0152-2020.
Hematopoietic Stem Cell Transplantation and Vasculopathy Associated With STAT3-Dominant-Negative Hyper-IgE Syndrome.
Ponsford M, Clark J, Mock J, Abinun M, Carne E, El-Shanawany T
Front Pediatr. 2020; 8:575.
PMID: 33014947
PMC: 7511721.
DOI: 10.3389/fped.2020.00575.
Retained primary teeth in STAT3 hyper-IgE syndrome: early intervention in childhood is essential.
Meixner I, Hagl B, Kroner C, Spielberger B, Paschos E, Duckers G
Orphanet J Rare Dis. 2020; 15(1):244.
PMID: 32912316
PMC: 7488068.
DOI: 10.1186/s13023-020-01516-3.
Histone Deacetylase Inhibitors and IL21 Cooperate to Reprogram Human Effector CD8 T Cells to Memory T Cells.
Wang J, Hasan F, Frey A, Li H, Park J, Pan K
Cancer Immunol Res. 2020; 8(6):794-805.
PMID: 32213626
PMC: 7269845.
DOI: 10.1158/2326-6066.CIR-19-0619.
Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome.
Beziat V, Tavernier S, Chen Y, Ma C, Materna M, Laurence A
J Exp Med. 2020; 217(6).
PMID: 32207811
PMC: 7971136.
DOI: 10.1084/jem.20191804.
A deep intronic splice mutation of underlies hyper IgE syndrome by negative dominance.
Khourieh J, Rao G, Habib T, Avery D, Lefevre-Utile A, Chandesris M
Proc Natl Acad Sci U S A. 2019; 116(33):16463-16472.
PMID: 31346092
PMC: 6697804.
DOI: 10.1073/pnas.1901409116.
Humoral immunodeficiencies: conferred risk of infections and benefits of immunoglobulin replacement therapy.
Gernez Y, Baker M, Maglione P
Transfusion. 2018; 58 Suppl 3:3056-3064.
PMID: 30536429
PMC: 6939302.
DOI: 10.1111/trf.15020.
Human hyper-IgE syndrome: singular or plural?.
Zhang Q, Boisson B, Beziat V, Puel A, Casanova J
Mamm Genome. 2018; 29(7-8):603-617.
PMID: 30094507
PMC: 6317873.
DOI: 10.1007/s00335-018-9767-2.
Gastrointestinal Manifestations of STAT3-Deficient Hyper-IgE Syndrome.
Arora M, Bagi P, Strongin A, Heimall J, Zhao X, Lawrence M
J Clin Immunol. 2017; 37(7):695-700.
PMID: 28803389
PMC: 8171578.
DOI: 10.1007/s10875-017-0429-z.
DOCK8 deficiency: clinical and immunological phenotype and treatment options - a review of 136 patients.
Aydin S, Kilic S, Aytekin C, Kumar A, Porras O, Kainulainen L
J Clin Immunol. 2015; 35(2):189-98.
PMID: 25627830
DOI: 10.1007/s10875-014-0126-0.
Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment.
Zhang Y, Yu X, Ichikawa M, Lyons J, Datta S, Lamborn I
J Allergy Clin Immunol. 2014; 133(5):1400-9, 1409.e1-5.
PMID: 24589341
PMC: 4016982.
DOI: 10.1016/j.jaci.2014.02.013.
Variable clinical expressivity of STAT3 mutation in hyperimmunoglobulin E syndrome: genetic and clinical studies of six patients.
Wolach O, Kuijpers T, Ben-Ari J, Gavrieli R, Feinstein-Goren N, Alders M
J Clin Immunol. 2014; 34(2):163-70.
PMID: 24452316
DOI: 10.1007/s10875-014-9988-4.
